Eli Lilly’s Taltz (ixekizumab) for plaque psoriasis produces positive results June 10, 2016 CenterWatch Staff
Arrien Pharmaceuticals initiated phase I trials of ARN-6039 for multiple sclerosis June 10, 2016 CenterWatch Staff
Survey: SCORR to present industry thoughts on Big Data, recruitment, confidentiality June 10, 2016 CenterWatch Staff
Southwest Research, Texas Biomedical awarded $3.4M for Ebola countermeasure June 8, 2016 CenterWatch Staff